Paul Chipperton

Paul Chipperton is currently the President and CEO of Insight Medbotics Inc, leading the company's development of an IGAR MR-guided robotic Breast Cancer diagnostic & treatment platform. With a background in business and finance, Paul has also held various leadership roles in companies such as Fero International Inc, Angel Investors Ontario, and Mperia Therapeutics Inc. Additionally, Paul has a strong academic background with an MBA from McGill University and experience as an Adjunct Lecturer at the Smith School of Business at Queen's University.